Jun 23, 2026
1:10000
For every 10000 shares held, investors received 1. The price per share adjusted from $0.00 to $2.00.
The split itself did not change the total investment value.
Neovacs SA (EURONEXT:ALNEV) operates in the Pharmaceuticals: major industry.
Neovacs SA company overviewNeovacs SA's most recent stock split was on June 23, 2026. It was a 1-for-10000 reverse split, so shareholders received 1 share for every 10000 they held.
Neovacs SA (EURONEXT:ALNEV) has split its stock 6 times: a 1-for-10000 reverse split on February 1, 2022, a 1-for-8000 reverse split on June 2, 2023, a 1-for-10000 reverse split on February 2, 2024, a 1-for-10000 reverse split on December 5, 2024, a 1-for-1000 reverse split on July 18, 2025, and a 1-for-10000 reverse split on June 23, 2026.
Neovacs SA has split its stock 6 times. This history records 6 reverse splits between February 1, 2022 and June 23, 2026.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Neovacs SA's 1-for-10000 reverse split on June 23, 2026, every 10000 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Neovacs SA has not announced a new split in our records. Its most recent split was on June 23, 2026, less than a year ago. Companies announce splits in advance, and any new EURONEXT:ALNEV split will appear on this page.
Already premium?